Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Published:23rd Aug, 2021 at 3:39 PM

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Also Read

ABVP continues push for Cancellation after NLSIU defers Umar Khalid Documentary Screening

Supreme Court stays Gujarat HC case on AI deepfakes after Centre seeks transfer of matter to SC

CJI Surya Kant proposes register on arbitrators’ conflicts, caseload

Refusing to return child's volleyball, asking him to bring parent not abetment of suicide: Karnataka HC

Karnataka HC rejects plea against S Vidyashankar's appointment as VC of Visvesvaraya University